Global RNA-Targeted Small Molecules Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global RNA-Targeted Small Molecules Market Size 2017-2028

2.1.2 RNA-Targeted Small Molecules Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 RNA-Targeted Small Molecules Segment by Type

2.2.1 mRNA Translation Regulation

2.2.2 RNA Splicing Modification

2.2.3 Direct RNA Targeting

2.2.4 Indirect RNA Targeting - Epitranscriptomics

2.3 RNA-Targeted Small Molecules Market Size by Type

2.3.1 RNA-Targeted Small Molecules Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2022)

2.4 RNA-Targeted Small Molecules Segment by Application

2.4.1 Hospitals

2.4.2 Laboratories

2.4.3 Phamacy

2.5 RNA-Targeted Small Molecules Market Size by Application

2.5.1 RNA-Targeted Small Molecules Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2022)

3 RNA-Targeted Small Molecules Market Size by Player

3.1 RNA-Targeted Small Molecules Market Size Market Share by Players

3.1.1 Global RNA-Targeted Small Molecules Revenue by Players (2020-2022)

3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2020-2022)

3.2 Global RNA-Targeted Small Molecules Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 RNA-Targeted Small Molecules by Regions

4.1 RNA-Targeted Small Molecules Market Size by Regions (2017-2022)

4.2 Americas RNA-Targeted Small Molecules Market Size Growth (2017-2022)

4.3 APAC RNA-Targeted Small Molecules Market Size Growth (2017-2022)

4.4 Europe RNA-Targeted Small Molecules Market Size Growth (2017-2022)

4.5 Middle East & Africa RNA-Targeted Small Molecules Market Size Growth (2017-2022)

5 Americas

5.1 Americas RNA-Targeted Small Molecules Market Size by Country (2017-2022)

5.2 Americas RNA-Targeted Small Molecules Market Size by Type (2017-2022)

5.3 Americas RNA-Targeted Small Molecules Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC RNA-Targeted Small Molecules Market Size by Region (2017-2022)

6.2 APAC RNA-Targeted Small Molecules Market Size by Type (2017-2022)

6.3 APAC RNA-Targeted Small Molecules Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe RNA-Targeted Small Molecules by Country (2017-2022)

7.2 Europe RNA-Targeted Small Molecules Market Size by Type (2017-2022)

7.3 Europe RNA-Targeted Small Molecules Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa RNA-Targeted Small Molecules by Region (2017-2022)

8.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2017-2022)

8.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global RNA-Targeted Small Molecules Market Forecast

10.1 Global RNA-Targeted Small Molecules Forecast by Regions (2023-2028)

10.1.1 Global RNA-Targeted Small Molecules Forecast by Regions (2023-2028)

10.1.2 Americas RNA-Targeted Small Molecules Forecast

10.1.3 APAC RNA-Targeted Small Molecules Forecast

10.1.4 Europe RNA-Targeted Small Molecules Forecast

10.1.5 Middle East & Africa RNA-Targeted Small Molecules Forecast

10.2 Americas RNA-Targeted Small Molecules Forecast by Country (2023-2028)

10.2.1 United States RNA-Targeted Small Molecules Market Forecast

10.2.2 Canada RNA-Targeted Small Molecules Market Forecast

10.2.3 Mexico RNA-Targeted Small Molecules Market Forecast

10.2.4 Brazil RNA-Targeted Small Molecules Market Forecast

10.3 APAC RNA-Targeted Small Molecules Forecast by Region (2023-2028)

10.3.1 China RNA-Targeted Small Molecules Market Forecast

10.3.2 Japan RNA-Targeted Small Molecules Market Forecast

10.3.3 Korea RNA-Targeted Small Molecules Market Forecast

10.3.4 Southeast Asia RNA-Targeted Small Molecules Market Forecast

10.3.5 India RNA-Targeted Small Molecules Market Forecast

10.3.6 Australia RNA-Targeted Small Molecules Market Forecast

10.4 Europe RNA-Targeted Small Molecules Forecast by Country (2023-2028)

10.4.1 Germany RNA-Targeted Small Molecules Market Forecast

10.4.2 France RNA-Targeted Small Molecules Market Forecast

10.4.3 UK RNA-Targeted Small Molecules Market Forecast

10.4.4 Italy RNA-Targeted Small Molecules Market Forecast

10.4.5 Russia RNA-Targeted Small Molecules Market Forecast

10.5 Middle East & Africa RNA-Targeted Small Molecules Forecast by Region (2023-2028)

10.5.1 Egypt RNA-Targeted Small Molecules Market Forecast

10.5.2 South Africa RNA-Targeted Small Molecules Market Forecast

10.5.3 Israel RNA-Targeted Small Molecules Market Forecast

10.5.4 Turkey RNA-Targeted Small Molecules Market Forecast

10.5.5 GCC Countries RNA-Targeted Small Molecules Market Forecast

10.6 Global RNA-Targeted Small Molecules Forecast by Type (2023-2028)

10.7 Global RNA-Targeted Small Molecules Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Accent Therapeutics

11.1.1 Accent Therapeutics Company Information

11.1.2 Accent Therapeutics RNA-Targeted Small Molecules Product Offered

11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Accent Therapeutics Main Business Overview

11.1.5 Accent Therapeutics Latest Developments

11.2 Anima Biotech Inc.

11.2.1 Anima Biotech Inc. Company Information

11.2.2 Anima Biotech Inc. RNA-Targeted Small Molecules Product Offered

11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Anima Biotech Inc. Main Business Overview

11.2.5 Anima Biotech Inc. Latest Developments

11.3 Arrakis Pharmaceuticals

11.3.1 Arrakis Pharmaceuticals Company Information

11.3.2 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product Offered

11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Arrakis Pharmaceuticals Main Business Overview

11.3.5 Arrakis Pharmaceuticals Latest Developments

11.4 Epics Therapeutics

11.4.1 Epics Therapeutics Company Information

11.4.2 Epics Therapeutics RNA-Targeted Small Molecules Product Offered

11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Epics Therapeutics Main Business Overview

11.4.5 Epics Therapeutics Latest Developments

11.5 Expansion Therapeutics

11.5.1 Expansion Therapeutics Company Information

11.5.2 Expansion Therapeutics RNA-Targeted Small Molecules Product Offered

11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Expansion Therapeutics Main Business Overview

11.5.5 Expansion Therapeutics Latest Developments

11.6 Gotham Therapeutics

11.6.1 Gotham Therapeutics Company Information

11.6.2 Gotham Therapeutics RNA-Targeted Small Molecules Product Offered

11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Gotham Therapeutics Main Business Overview

11.6.5 Gotham Therapeutics Latest Developments

11.7 H3 Biomedicine

11.7.1 H3 Biomedicine Company Information

11.7.2 H3 Biomedicine RNA-Targeted Small Molecules Product Offered

11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 H3 Biomedicine Main Business Overview

11.7.5 H3 Biomedicine Latest Developments

11.8 Ribometrix

11.8.1 Ribometrix Company Information

11.8.2 Ribometrix RNA-Targeted Small Molecules Product Offered

11.8.3 Ribometrix RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ribometrix Main Business Overview

11.8.5 Ribometrix Latest Developments

11.9 Skyhawk Therapeutics

11.9.1 Skyhawk Therapeutics Company Information

11.9.2 Skyhawk Therapeutics RNA-Targeted Small Molecules Product Offered

11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Skyhawk Therapeutics Main Business Overview

11.9.5 Skyhawk Therapeutics Latest Developments

11.10 STORM Therapeutics

11.10.1 STORM Therapeutics Company Information

11.10.2 STORM Therapeutics RNA-Targeted Small Molecules Product Offered

11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 STORM Therapeutics Main Business Overview

11.10.5 STORM Therapeutics Latest Developments

11.11 Twentyeight-Seven Therapeutics

11.11.1 Twentyeight-Seven Therapeutics Company Information

11.11.2 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product Offered

11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Twentyeight-Seven Therapeutics Main Business Overview

11.11.5 Twentyeight-Seven Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. RNA-Targeted Small Molecules Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of mRNA Translation Regulation

Table 3. Major Players of RNA Splicing Modification

Table 4. Major Players of Direct RNA Targeting

Table 5. Major Players of Indirect RNA Targeting - Epitranscriptomics

Table 6. RNA-Targeted Small Molecules Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global RNA-Targeted Small Molecules Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2022)

Table 9. RNA-Targeted Small Molecules Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global RNA-Targeted Small Molecules Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2022)

Table 12. Global RNA-Targeted Small Molecules Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global RNA-Targeted Small Molecules Revenue Market Share by Player (2020-2022)

Table 14. RNA-Targeted Small Molecules Key Players Head office and Products Offered

Table 15. RNA-Targeted Small Molecules Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global RNA-Targeted Small Molecules Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global RNA-Targeted Small Molecules Market Size Market Share by Regions (2017-2022)

Table 20. Americas RNA-Targeted Small Molecules Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas RNA-Targeted Small Molecules Market Size Market Share by Country (2017-2022)

Table 22. Americas RNA-Targeted Small Molecules Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2022)

Table 24. Americas RNA-Targeted Small Molecules Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2022)

Table 26. APAC RNA-Targeted Small Molecules Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC RNA-Targeted Small Molecules Market Size Market Share by Region (2017-2022)

Table 28. APAC RNA-Targeted Small Molecules Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2022)

Table 30. APAC RNA-Targeted Small Molecules Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2022)

Table 32. Europe RNA-Targeted Small Molecules Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe RNA-Targeted Small Molecules Market Size Market Share by Country (2017-2022)

Table 34. Europe RNA-Targeted Small Molecules Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2022)

Table 36. Europe RNA-Targeted Small Molecules Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa RNA-Targeted Small Molecules Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of RNA-Targeted Small Molecules

Table 45. Key Market Challenges & Risks of RNA-Targeted Small Molecules

Table 46. Key Industry Trends of RNA-Targeted Small Molecules

Table 47. Global RNA-Targeted Small Molecules Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global RNA-Targeted Small Molecules Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global RNA-Targeted Small Molecules Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global RNA-Targeted Small Molecules Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global RNA-Targeted Small Molecules Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global RNA-Targeted Small Molecules Market Size Market Share Forecast by Application (2023-2028)

Table 53. Accent Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 54. Accent Therapeutics RNA-Targeted Small Molecules Product Offered

Table 55. Accent Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Accent Therapeutics Main Business

Table 57. Accent Therapeutics Latest Developments

Table 58. Anima Biotech Inc. Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 59. Anima Biotech Inc. RNA-Targeted Small Molecules Product Offered

Table 60. Anima Biotech Inc. Main Business

Table 61. Anima Biotech Inc. RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Anima Biotech Inc. Latest Developments

Table 63. Arrakis Pharmaceuticals Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 64. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product Offered

Table 65. Arrakis Pharmaceuticals Main Business

Table 66. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Arrakis Pharmaceuticals Latest Developments

Table 68. Epics Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 69. Epics Therapeutics RNA-Targeted Small Molecules Product Offered

Table 70. Epics Therapeutics Main Business

Table 71. Epics Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Epics Therapeutics Latest Developments

Table 73. Expansion Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 74. Expansion Therapeutics RNA-Targeted Small Molecules Product Offered

Table 75. Expansion Therapeutics Main Business

Table 76. Expansion Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Expansion Therapeutics Latest Developments

Table 78. Gotham Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 79. Gotham Therapeutics RNA-Targeted Small Molecules Product Offered

Table 80. Gotham Therapeutics Main Business

Table 81. Gotham Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Gotham Therapeutics Latest Developments

Table 83. H3 Biomedicine Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 84. H3 Biomedicine RNA-Targeted Small Molecules Product Offered

Table 85. H3 Biomedicine Main Business

Table 86. H3 Biomedicine RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. H3 Biomedicine Latest Developments

Table 88. Ribometrix Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 89. Ribometrix RNA-Targeted Small Molecules Product Offered

Table 90. Ribometrix Main Business

Table 91. Ribometrix RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Ribometrix Latest Developments

Table 93. Skyhawk Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 94. Skyhawk Therapeutics RNA-Targeted Small Molecules Product Offered

Table 95. Skyhawk Therapeutics Main Business

Table 96. Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Skyhawk Therapeutics Latest Developments

Table 98. STORM Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 99. STORM Therapeutics RNA-Targeted Small Molecules Product Offered

Table 100. STORM Therapeutics Main Business

Table 101. STORM Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. STORM Therapeutics Latest Developments

Table 103. Twentyeight-Seven Therapeutics Details, Company Type, RNA-Targeted Small Molecules Area Served and Its Competitors

Table 104. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product Offered

Table 105. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Twentyeight-Seven Therapeutics Main Business

Table 107. Twentyeight-Seven Therapeutics Latest Developments

List of Figures

Figure 1. RNA-Targeted Small Molecules Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global RNA-Targeted Small Molecules Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global RNA-Targeted Small Molecules Market Size Market Share by Type in 2021

Figure 7. RNA-Targeted Small Molecules in Hospitals

Figure 8. Global RNA-Targeted Small Molecules Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. RNA-Targeted Small Molecules in Laboratories

Figure 10. Global RNA-Targeted Small Molecules Market: Laboratories (2017-2022) & ($ Millions)

Figure 11. RNA-Targeted Small Molecules in Phamacy

Figure 12. Global RNA-Targeted Small Molecules Market: Phamacy (2017-2022) & ($ Millions)

Figure 13. Global RNA-Targeted Small Molecules Market Size Market Share by Application in 2021

Figure 14. Global RNA-Targeted Small Molecules Revenue Market Share by Player in 2021

Figure 15. Global RNA-Targeted Small Molecules Market Size Market Share by Regions (2017-2022)

Figure 16. Americas RNA-Targeted Small Molecules Market Size 2017-2022 ($ Millions)

Figure 17. APAC RNA-Targeted Small Molecules Market Size 2017-2022 ($ Millions)

Figure 18. Europe RNA-Targeted Small Molecules Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa RNA-Targeted Small Molecules Market Size 2017-2022 ($ Millions)

Figure 20. Americas RNA-Targeted Small Molecules Value Market Share by Country in 2021

Figure 21. Americas RNA-Targeted Small Molecules Consumption Market Share by Type in 2021

Figure 22. Americas RNA-Targeted Small Molecules Market Size Market Share by Application in 2021

Figure 23. United States RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC RNA-Targeted Small Molecules Market Size Market Share by Region in 2021

Figure 28. APAC RNA-Targeted Small Molecules Market Size Market Share by Application in 2021

Figure 29. China RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 33. India RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe RNA-Targeted Small Molecules Market Size Market Share by Country in 2021

Figure 36. Europe RNA-Targeted Small Molecules Market Size Market Share by Type in 2021

Figure 37. Europe RNA-Targeted Small Molecules Market Size Market Share by Application in 2021

Figure 38. Germany RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 39. France RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa RNA-Targeted Small Molecules Market Size Market Share by Application in 2021

Figure 46. Egypt RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country RNA-Targeted Small Molecules Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 52. APAC RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 53. Europe RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 55. United States RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 56. Canada RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 57. Mexico RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 58. Brazil RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 59. China RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 60. Japan RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 61. Korea RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 63. India RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 64. Australia RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 65. Germany RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 66. France RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 67. UK RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 68. Italy RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 69. Russia RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 70. Spain RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 71. Egypt RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 72. South Africa RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 73. Israel RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 74. Turkey RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries RNA-Targeted Small Molecules Market Size 2023-2028 ($ Millions)